NeuroIntact develops a targeted temperature management system that utilizes thermoelectric cooling to lower brain temperature noninvasively through the nasal cavity, effectively reducing elevated intracranial pressure and brain edema. This method minimizes systemic side effects and allows patients to remain awake, enhancing recovery outcomes for individuals with traumatic brain injuries and strokes.
Funding
Funding not disclosed
Founders
Product
Problem
Elevated intracranial pressure and cerebral edema following traumatic brain injury or stroke can lead to further brain damage and life-threatening complications. Current methods for managing these conditions may involve systemic cooling, which can cause unwanted side effects, or pharmaceutical interventions that require patient sedation.
Solution
NeuroIntact offers a targeted temperature management (TTM) system that utilizes thermoelectric cooling to noninvasively lower brain temperature via the nasal cavity. This approach aims to reduce elevated intracranial pressure and brain edema while minimizing systemic side effects and allowing patients to remain awake. By selectively cooling the brain, the system seeks to improve neurological outcomes and enhance recovery for individuals with traumatic brain injuries and strokes. The technology leverages a patented method for cooling the brain using thermoelectric elements and controlled airflow.
Target Audience
The primary target audience includes medical professionals treating patients with traumatic brain injuries and strokes, specifically neurosurgeons, neurologists, and critical care physicians.
Features
- Noninvasive brain cooling via nasal cavity delivery
- Thermoelectric cooling technology for precise temperature control
- Targeted temperature management to reduce intracranial pressure and edema
- System design allows patients to remain awake during treatment
- Reduced risk of systemic side effects compared to whole-body cooling
- Patented method for cooling air and delivering it through the nasal cavity